News ArchivesRead News
Bill to regulate stem-cell research rejected by Senate
Thursday April 21, 2005
Olympia, WA, Aug. 12, 2005(AP) - OLYMPIA -- After days of delay, the Senate killed a bill yesterday that would permit and regulate stem-cell research, with two Republicans who originally supported the measure jumping back to join their caucus.
Senate Minority Leader Bill Finkbeiner, R-Kirkland, was the lone Republican to vote for the bill, which was defeated 26-23.
The measure would permit stem-cell research, including the use of human embryonic stem cells, but prohibit reproductive cloning.
Senate Democrats said they thought they had enough votes to pass the bill, but a few senators apparently changed their minds.
Sen. Mike Hewitt, R-Walla Walla, voted against the bill after giving a floor speech Friday in which he said he was voting in favor. He said he lost his grandfather and a close friend to Alzheimers and that his father died from complications of diabetes.
Hewitt did not return phone calls yesterday afternoon.
Senate Republicans tried various tactics to delay yesterdays vote, including asking that the Senate adjourn early, and seeking to send the bill back to committee.
The stalling frustrated Senate Democrats, who have been waiting to vote on the bill since an emotional debate Thursday.
Embryonic stem cells are at the heart of the controversy. Such cells come from human embryos created through in-vitro fertilization. The embryos are destroyed when stem cells are extracted.
Scientists believe embryonic stem-cell research could lead to cures for diseases such as Parkinsons, Alzheimers and diabetes. Opponents say destroying the embryos is destroying human life.
Senate Democrats say the bill still has a chance. In an attempt to keep it alive, Majority Leader Lisa Brown, D-Spokane, switched her vote from yes to no. Sen. Jeanne Kohl-Welles, D-Seattle, said that because Brown voted with the majority, Senate rules will allow Brown to bring the bill back for reconsideration.
Recent NewsOct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show